Monday, 14 September 2026
Monday, 14 September 2026
- In brief
- 1Baby girls exposed to paracetamol in the womb had 40% smaller ovaries. The study cannot say the drug caused it.
- 2Cash from birth changed a DNA ageing test
- 3Secret deals may shrink promised Medicare savings
- 41.9 million Britons' health data, checked for bias
- 5Cancer treatment reshapes healthy gullet cells
- 6Ancestry and diabetes, compared inside families
- 7India's newborn heart-defect deaths fall slowly
- 8Sons make births harder in many mammals
- 9Europe offers 32 million euros for healthy-ageing research
14 Sept · Biotech · In brief
Biotech · Monday, 14 September 2026
Biotech, in brief
9 stories · 11 sources
Swipe up for the day in brief ↑Scroll down for the day in brief ↓
What is moving · 1 of 3
What reaches a baby early in life
Girls exposed to paracetamol in the womb had smaller ovaries at three months.
What is moving · 2 of 3
Who takes part in a study
Only 13% of the 1.9 million people in Our Future Health, a UK study, live in the poorest fifth of areas, against 20% nationally.
What is moving · 3 of 3
Medicines changing healthy tissue
Chemotherapy with radiation let cells with a damaged cancer-guard gene spread in the healthy gullet lining of cancer patients.
9 stories
- 1Baby girls exposed to paracetamol in the womb had 40% smaller ovaries. The study cannot say the drug caused it.
- 2Cash from birth changed a DNA ageing test
- 3Secret deals may shrink promised Medicare savings
- 41.9 million Britons' health data, checked for bias
- 5Cancer treatment reshapes healthy gullet cells
7 sources
Biotech, in brief
- 1Tylenol use in pregnancy may be linked with uterus, ovary changes in daughters
- 2Common painkiller use in early pregnancy linked to smaller ovaries and testes
- 3Effects of a randomized controlled trial of unconditional cash transfers on epigenetic measures of ageing and cognition in children and mothers
- 5Phenomic profiles and disease patterns of 1.9 million participants from Our Future Health
- 6Cancer Treatment Genetic Effects in Healthy Cells May Reveal Clues to Side Effects and Resistance
- 7Cancer treatment alters mutant selection in normal esophagus
- 8Within-family effect of ancestry on complex traits in a Mexican population
Baby girls exposed to paracetamol in the womb had 40% smaller ovaries. The study cannot say the drug caused it.
Swipe up for the story ↑Scroll down for the story ↓
Researchers in Denmark examined 302 baby girls at about three months old.
Their mothers' use of paracetamol, the painkiller sold as Tylenol in the US, had been tracked through pregnancy.
Who is involved
Margit Bistrup Fischer
a researcher at Copenhagen University Hospital-Rigshospitalet in Denmark; she led the study
Who is involved
Severine Mazaud-Guittot
a researcher at INSERM, France's national health research institute; she says caution is wise, especially early in pregnancy
Why it matters
The next evidence is the paper on the boys, and whether anyone follows these girls to the age when their fertility can actually be measured.
What's really going on
A Danish study found that baby girls exposed to paracetamol in the womb had smaller ovaries, and it cannot show the drug caused it.
What's really going on
The test that could show it would mean giving pregnant women the drug by chance, which the study's leader says would be unethical, so experts reading the same numbers disagree about whether advice to pregnant women should change.
Why it works on people
A figure like 40% smaller ovaries sounds like a verdict on a girl's future, but it was measured in babies at three months, and nobody can yet say what it means for fertility.
Who pays
Pregnant women in pain
Most other painkillers are not recommended in pregnancy because they can harm the baby, so they are left weighing one drug against mixed expert advice.
Nobody knows yet
Whether paracetamol caused the smaller ovaries at all.
Mothers who take it may be sicker, have infections, eat differently or differ in their genes, and the team could not rule all of that out.
Nobody knows yet
Whether the girls will have lower fertility or an earlier menopause.
The girls were measured at three months, and finding out needs follow-up into adult life, which the study's leader says is hard to do.
Nobody knows yet
Whether the result is partly chance.
A UCL specialist says the team ran many analyses, which raises the odds of a chance finding.
Nobody knows yet
What the paper on the boys shows in detail.
It has been accepted by the journal but not published, so only the headline finding of smaller testes is public.
The short version
That's the story in short.
The whole story has 13 more parts.
or swipe up for the next storyor scroll on for the next story ↓
The whole story, in 13 parts ↓
Part 1 of 13 · Who else is involved
Dimitrios Siassakos
a pregnancy specialist at University College London; he says the paper would not change his advice
Part 1 of 13 · Who else is involved
Brian Lee
a researcher at the University of Pennsylvania; he warns that sicker mothers, not the drug, may explain the link
Part 2 of 13 · How it unfolded
2022
Research co-written by a French scientist shows paracetamol harms the growth of human ovary tissue kept in the lab.
2025
Another study shows paracetamol affects the growth of human embryo cells.
Part 3 of 13
Paracetamol is the drug pregnant women take most often.
Part 4 of 13
Girls exposed in the womb had, on average, 40% smaller ovaries, 23% fewer follicles (the sacs that hold immature eggs) and 13% smaller wombs.
Part 5 of 13
Girls first exposed before week 17 of pregnancy also had less anti-Mullerian hormone, a hormone that signals how many eggs the ovaries hold and how good they are.
Part 6 of 13
Higher doses went with bigger differences, and no mother took more than the daily maximum of 4,000mg.
Part 7 of 13
Most of the mothers took it for headaches or muscle and joint pain, not for fever.
Part 8 of 13
In a second group of 1,210 girls born in Copenhagen between 1997 and 2002, exposure in the womb went with smaller ovaries in adolescence.
Part 8 of 13
The same group had smaller wombs at puberty.
Part 9 of 13
A girl is born with all the eggs she will ever have, so her egg supply is set before birth.
Part 10 of 13
Baby boys whose mothers took paracetamol had smaller testes on average, in a second paper accepted but not yet published.
Part 11 of 13
The study cannot prove the drug caused any of this.
Part 11 of 13
The illness that led a mother to take it, or chance, could explain the link.
Part 12 of 13
Nobody can yet say whether these girls will have lower fertility or reach menopause earlier.
Part 12 of 13
Finding out needs many years of follow-up.
Part 13 of 13
Guidelines still recommend paracetamol for pain and fever in pregnancy.
Part 13 of 13
The study's leader says a high fever or severe pain left untreated carries its own risks.
2 sources
Baby girls exposed to paracetamol in the womb had 40% smaller ovaries. The study cannot say the drug caused it.
The full story
Baby girls exposed to paracetamol in the womb had 40% smaller ovaries. The study cannot say the drug caused it.
Researchers in Denmark examined 302 baby girls at about three months old. Their mothers' use of paracetamol, the painkiller sold as Tylenol in the US, had been tracked through pregnancy.
Paracetamol is the drug pregnant women take most often.
Girls exposed in the womb had, on average, 40% smaller ovaries, 23% fewer follicles (the sacs that hold immature eggs) and 13% smaller wombs.
Girls first exposed before week 17 of pregnancy also had less anti-Mullerian hormone, a hormone that signals how many eggs the ovaries hold and how good they are.
Higher doses went with bigger differences, and no mother took more than the daily maximum of 4,000mg.
Most of the mothers took it for headaches or muscle and joint pain, not for fever.
In a second group of 1,210 girls born in Copenhagen between 1997 and 2002, exposure in the womb went with smaller ovaries in adolescence.
A girl is born with all the eggs she will ever have, so her egg supply is set before birth.
Baby boys whose mothers took paracetamol had smaller testes on average, in a second paper accepted but not yet published.
The study cannot prove the drug caused any of this. The illness that led a mother to take it, or chance, could explain the link.
Nobody can yet say whether these girls will have lower fertility or reach menopause earlier. Finding out needs many years of follow-up.
Guidelines still recommend paracetamol for pain and fever in pregnancy. The study's leader says a high fever or severe pain left untreated carries its own risks.
Why it matters. The next evidence is the paper on the boys, and whether anyone follows these girls to the age when their fertility can actually be measured.
Cash from birth changed a DNA ageing test
Swipe up for the story ↑Scroll down for the story ↓
A US trial called Baby's First Years gave mothers on low incomes either $333 or $20 a month, decided by chance, starting shortly after their baby was born.
The larger gift added about $4,000 a year, roughly 18% of family income.
At age four, children in the $333 group scored slower on DunedinPACE, a DNA test on saliva that estimates how fast the body is ageing.
The difference was small, and the mothers' own tests did not change.
Why it matters
Because the gifts were handed out by chance, the difference comes from the money and not from other things that go with being poor.
Why it matters
The payments ended after each child's sixth birthday, and nobody knows yet whether the difference lasts or affects health.
How it works
Why the same exposure can change a baby and leave the mother unchanged
How it works
A body that is still being built can be changed by what reaches it, while a grown body has mostly finished building.
How it works · step 1 of 5
A baby's organs are built in stages, many of them before birth
How it works · step 2 of 5
Whatever reaches an organ while it is forming can change how it forms
How it works · step 3 of 5
Some of what is built then is never added to later, like a girl's supply of eggs
How it works · step 4 of 5
A grown body finished those stages long ago
How it works · step 5 of 5
So one exposure can leave a mark on a child and little on the mother
The twist
What reaches a mother can matter more for her child, because the child's body is still being built while hers is already finished.
Seen the same day
Money paid to the mothers changed the four-year-olds' DNA test and not the mothers' own. The researchers call the first five years of life an especially sensitive time.
Seen the same day
The idea is that a mother sends more energy to a son while he is forming in the womb, so he is born bigger.
The catch
Timing only matters if the exposure does something: the Danish study cannot show paracetamol caused the change, and the cash trial does not yet know whether its difference lasts.
The whole
Pregnant women, the doctors who write guidelines and the people deciding whether to give money to poor families all make choices that show up in a child's body years later.
The whole
None of them can see those results on the day they choose.
Who gains
Children in low-income US families given $333 a month
At age four they scored slower on a DNA test of how fast the body is ageing than children whose families got $20.
Nobody knows yet
Whether the children's slower DNA ageing test lasts, or means better health.
The payments ended after each child's sixth birthday, and the test was taken at age four, before any health effects could show.
Good news
In a US trial, children in low-income families given $333 a month from birth scored slower at age four on a DNA test of how fast the body is ageing than children whose families got $20.
1 source
Cash from birth changed a DNA ageing test
The full story
Cash from birth changed a DNA ageing test
A US trial called Baby's First Years gave mothers on low incomes either $333 or $20 a month, decided by chance, starting shortly after their baby was born.
Why it matters. Because the gifts were handed out by chance, the difference comes from the money and not from other things that go with being poor.
Secret deals may shrink promised Medicare savings
Swipe up for the story ↑Scroll down for the story ↓
Medicare is the US government's health insurance for older people.
The Trump administration says tying what Medicare pays for drugs to 19 other rich countries would save $26 billion over several years.
It is setting up two pilot schemes, GLOBE and GUARD.
They make drug companies pay extra rebates when a medicine costs more in the US than the lowest figure among those countries.
A new analysis reported by STAT says confidential deals with more than two dozen drug companies could cut those savings by as much as 80%.
Why it matters
If the analysis holds, Medicare would save far less on drugs than the Trump administration announced.
Who gains
Drug companies that signed confidential price deals with the Trump administration
The GLOBE and GUARD schemes make companies pay rebates when US prices are higher than abroad, and the analysis says their deals could cut the resulting savings by as much as 80%.
Who pays
Medicare, the US government's health insurance for older people
The $26 billion it was told to expect from tying prices to other countries could shrink by as much as 80% because of the confidential deals.
Nobody knows yet
How much the secret drug-price deals really take out of Medicare's savings.
The deal terms are confidential and the detailed rules for GLOBE and GUARD are not out yet.
1 source
Secret deals may shrink promised Medicare savings
The full story
Secret deals may shrink promised Medicare savings
Medicare is the US government's health insurance for older people. The Trump administration says tying what Medicare pays for drugs to 19 other rich countries would save $26 billion over several years.
Why it matters. If the analysis holds, Medicare would save far less on drugs than the Trump administration announced.
1.9 million Britons' health data, checked for bias
Swipe up for the story ↑Scroll down for the story ↓
Our Future Health, a UK study that aims to sign up 5 million adults, has published a first look at 1.9 million of them in the journal Nature Medicine.
More than 2.5 million people have registered since late 2022, making it the largest study of its kind.
Its members broadly match the UK by age and sex, but only 13% come from the poorest fifth of areas, against 20% nationally.
They reported more depression and anxiety than national figures, and fewer lung cancers.
Why it matters
About 4.5% of the people invited agreed to join, so the authors say the study should not yet be used to work out how common diseases are across the country.
Why it matters
They also suggest long waits for NHS care, Britain's public health service, may have drawn in people with health problems that were not being treated.
Who gains
Researchers who use Our Future Health
They get health data on more than 1.9 million consenting UK adults, the largest study of its kind.
Who pays
People in the poorest parts of the UK
They make up 13% of Our Future Health against 20% of the country, so findings from it may fit them least well.
Nobody knows yet
How much of Our Future Health's picture of disease comes from who chose to join.
About 4.5% of the people invited signed up, and the authors think long NHS waits may have drawn in people with untreated health problems.
Good news
More than 2.5 million adults in the UK have signed up since late 2022 to give their health data to one study, Our Future Health.
1 source
1.9 million Britons' health data, checked for bias
The full story
1.9 million Britons' health data, checked for bias
Our Future Health, a UK study that aims to sign up 5 million adults, has published a first look at 1.9 million of them in the journal Nature Medicine.
Why it matters. About 4.5% of the people invited agreed to join, so the authors say the study should not yet be used to work out how common diseases are across the country.
Cancer treatment reshapes healthy gullet cells
Swipe up for the story ↑Scroll down for the story ↓
Scientists at the Wellcome Sanger Institute in England read the DNA of healthy gullet lining from 70 people who had surgery for gullet cancer.
By age 60 to 70, almost every cell in a healthy gullet carries some mutations, and most never cause cancer.
In patients given chemotherapy with radiation, cells with mutations in TP53, a gene that normally stops damaged cells growing, had spread further.
After chemotherapy alone, cells with mutations that help them survive the drug 5-fluorouracil had spread.
Why it matters
The team says a few weeks of treatment can change a pattern of cells in a healthy organ that took decades to form.
Why it matters
Reading healthy tissue like this could help explain why some patients get side effects from cancer drugs.
Nobody knows yet
What the spreading mutant cells in treated gullets do next.
The study read healthy tissue removed at surgery after treatment, and the reports we could read describe no later follow-up of those patients.
2 sources
Cancer treatment reshapes healthy gullet cells
The full story
Cancer treatment reshapes healthy gullet cells
Scientists at the Wellcome Sanger Institute in England read the DNA of healthy gullet lining from 70 people who had surgery for gullet cancer.
Why it matters. The team says a few weeks of treatment can change a pattern of cells in a healthy organ that took decades to form.
Ancestry and diabetes, compared inside families
Swipe up for the story ↑Scroll down for the story ↓
Researchers used the Mexico City Prospective Study to ask whether differences between ancestry groups come from genes or from surroundings.
They measured ancestry and 15 traits in 52,583 unrelated people and 39,714 relatives from 17,627 families.
Comparing relatives removes the link between ancestry and home life that confuses comparisons between whole groups.
Within families, more Indigenous American ancestry still went with shorter height and a higher risk of type 2 diabetes.
Why it matters
Across the whole population, ancestry also went with years of schooling, but that link disappeared inside families.
Why it matters
That points to surroundings, not genes, as the cause of the schooling gap, and to a real genetic part in height and diabetes.
1 source
Ancestry and diabetes, compared inside families
The full story
Ancestry and diabetes, compared inside families
Researchers used the Mexico City Prospective Study to ask whether differences between ancestry groups come from genes or from surroundings.
Why it matters. Across the whole population, ancestry also went with years of schooling, but that link disappeared inside families.
India's newborn heart-defect deaths fall slowly
Swipe up for the story ↑Scroll down for the story ↓
About 9 in every 1,000 babies born in India have a heart defect, some 180,000 to 200,000 a year.
A study in the journal Pediatric Research used Global Burden of Disease figures, a worldwide set of health estimates, from 1990 to 2021.
India had about 1.5 million of the world's 8.6 million infant deaths from heart defects over those years.
Newborn deaths from heart defects fell 1.5% a year in India, against 2.2% worldwide.
Why it matters
Progress stalled from 2003 to 2013, then sped up nearly threefold from 2019 to 2021.
Why it matters
The authors put the economic loss from these deaths at $11.7 billion in 2021, and found large gaps in progress between parts of the country.
Who pays
Families in India whose babies are born with heart defects
Newborn deaths from heart defects fell more slowly in India than worldwide, with an estimated economic loss of $11.7 billion in 2021.
Nobody knows yet
Why India's fall in newborn heart-defect deaths stalled from 2003 to 2013.
The study reports the stall and the later speed-up, but the part we could read does not give a cause.
Good news
In India, the fall in deaths of newborn babies from heart defects stalled from 2003 to 2013. From 2019 to 2021 it sped up nearly threefold.
1 source
India's newborn heart-defect deaths fall slowly
The full story
India's newborn heart-defect deaths fall slowly
About 9 in every 1,000 babies born in India have a heart defect, some 180,000 to 200,000 a year.
Why it matters. Progress stalled from 2003 to 2013, then sped up nearly threefold from 2019 to 2021.
Sons make births harder in many mammals
Swipe up for the story ↑Scroll down for the story ↓
Nicole Grunstra of the University of Vienna and Jonathan Wells of University College London reviewed birth records for 140 mammal species.
Difficult labour was more common with male babies in humans, cattle, water buffalo, sheep, goats, captive antelope and Asian elephants.
Earlier work found mothers of boys in Nepal had an 18% higher chance of blocked labour.
Their idea is that mothers send more energy to sons in the womb, so the babies grow bigger.
Why it matters
About 700 people die giving birth every day around the world, and a baby's head too big for the birth canal is a leading cause.
Why it matters
The authors found little data on wild animals, and one outside scientist says they may be reading too much into what they found.
How it works
The idea is that a mother sends more energy to a son while he is forming in the womb, so he is born bigger.
The idea, in story 2: Why the same exposure can change a baby and leave the mother unchanged →Nobody knows yet
Whether sons really made births harder over evolution.
There is little data on wild animals, and a Harvard scientist says cases seen in the wild do not show a strong force.
1 source
Sons make births harder in many mammals
The full story
Sons make births harder in many mammals
Nicole Grunstra of the University of Vienna and Jonathan Wells of University College London reviewed birth records for 140 mammal species.
Why it matters. About 700 people die giving birth every day around the world, and a baby's head too big for the birth canal is a leading cause.
Europe offers 32 million euros for healthy-ageing research
Swipe up for the story ↑Scroll down for the story ↓
The European Innovation Council, an EU fund for risky new technology, is opening a 32 million euro call for research on healthy ageing.
The money is meant for five to eight projects, each lasting five years.
The EU expects the share of its people aged 85 and over to double from 3% to 6% by 2050.
Lifespans have grown, but the years people live in good health have not grown as fast.
Why it matters
The grants go to early ideas, meant to show that an approach to keeping people healthy for longer can work at all.
Who gains
Scientists working on healthy ageing in Europe
The European Innovation Council is opening 32 million euros for five to eight five-year projects.
1 source
Europe offers 32 million euros for healthy-ageing research
The full story
Europe offers 32 million euros for healthy-ageing research
The European Innovation Council, an EU fund for risky new technology, is opening a 32 million euro call for research on healthy ageing.
Why it matters. The grants go to early ideas, meant to show that an approach to keeping people healthy for longer can work at all.
That's the whole Biotech day.
9 stories, 11 sources.